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Abstract
Behaviour change is key to combating antimicrobial resistance.
Antimicrobial stewardship (AMS) programmes promote and monitor
judicious antibiotic use, but there is little consideration of behavioural and
social influences when designing interventions.  We outline a programme of
research which aims to co-design AMS interventions across healthcare
settings, by integrating data-science, evidence- synthesis,
behavioural-science and user-centred design.
The project includes three work-packages (WP):
Identifying patterns of prescribing):  analysis of electronicWP1 (
health-records to identify prescribing patterns in care-homes, primary-care,
and secondary-care. An online survey will investigate
consulting/antibiotic-seeking behaviours in members of the public.
 (Barriers and enablers to prescribing in practice): Semi-structuredWP2
interviews and observations of practice to identify barriers/enablers to
prescribing, influences on antibiotic-seeking behaviour and the
social/contextual factors underpinning prescribing. Systematic reviews of
AMS interventions to identify the components of existing interventions
associated with effectiveness. Design workshops to identify constraints
influencing the form of the intervention. Interviews conducted with
healthcare-professionals in community pharmacies, care-homes, primary-,
and secondary-care and with members of the public. Topic guides and
analysis based on the Theoretical Domains Framework.  Observations
conducted in care-homes, primary and secondary-care with analysis
drawing on grounded theory.  Systematic reviews of interventions in each
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 drawing on grounded theory.  Systematic reviews of interventions in each
setting will be conducted, and interventions described using the Behaviour
Change Technique taxonomy v1. Design workshops in care-homes,
primary-, and secondary care.
 (Co-production of interventions and dissemination). Findings will beWP3
integrated to identify opportunities for interventions, and assess whether
existing interventions target influences on antibiotic use. Stakeholder
panels will be assembled to co-design and refine interventions in each
setting, applying the Affordability, Practicability, Effectiveness,
Acceptability, Side-effects and Equity (APEASE) criteria to prioritise
candidate interventions. 
Outputs will inform development of new AMS interventions and/or
optimisation of existing interventions.  We will also develop web-resources
for stakeholders providing analyses of antibiotic prescribing patterns,
prescribing behaviours, and evidence reviews.
Keywords
Antimicrobial-stewardship, behaviour-change, interdisciplinary,
ethnography, epidemiology, user-centred design
 Christopher Fuller ( )Corresponding author: christopher.fuller@ucl.ac.uk
  : Conceptualization, Funding Acquisition, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing; Author roles: Shallcross L
: Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing;  : Project Administration,Lorencatto F Fuller C
Writing – Original Draft Preparation, Writing – Review & Editing;  : Conceptualization, Funding Acquisition, Supervision, Writing – OriginalTarrant C
Draft Preparation, Writing – Review & Editing;  : Conceptualization, Funding Acquisition, Supervision, Writing – Original Draft Preparation,West J
Writing – Review & Editing;  : Formal Analysis, Investigation, Methodology, Writing – Review & Editing;  : Formal Analysis,Traina R Smith C
Investigation, Methodology, Writing – Review & Editing;  : Formal Analysis, Investigation, Methodology, Writing – Review & Editing; Forbes G
: Formal Analysis, Investigation, Methodology, Writing – Review & Editing;  : Formal Analysis, Investigation,Crayton E Rockenschaub P
Methodology, Writing – Review & Editing;  : Formal Analysis, Investigation, Methodology, Writing – Review & Editing; Dutey-Magni P Richardson
: Formal Analysis, Investigation, Methodology, Writing – Review & Editing;  : Funding Acquisition, Methodology, Writing – Review &E Fragaszy E
Editing;  : Conceptualization, Funding Acquisition, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing; Michie S Hayward
: Conceptualization, Funding Acquisition, Supervision, Writing – Review & Editing;A
 No competing interests were disclosed.Competing interests:
 This work was supported by the Wellcome Trust through a Digital Innovator Award to FL [215742]. Funding for the project wasGrant information:
received from the Economic and Social Research Council as part of a Antimicrobial Resistance programme grant [ES-P008321-1].
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 © 2020 Shallcross L  . This is an open access article distributed under the terms of the  ,Copyright: et al Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Shallcross L, Lorencatto F, Fuller C   How to cite this article: et al. An interdisciplinary mixed-methods approach to developing
antimicrobial stewardship interventions: Protocol for the Preserving Antibiotics through Safe Stewardship (PASS) Research
 Wellcome Open Research 2020,  :8 ( )Programme [version 1; peer review: 2 approved] 5 https://doi.org/10.12688/wellcomeopenres.15554.1
 14 Jan 2020,  :8 ( ) First published: 5 https://doi.org/10.12688/wellcomeopenres.15554.1
Page 2 of 14
Wellcome Open Research 2020, 5:8 Last updated: 10 FEB 2020
Introduction
Since the 1940s, antibiotics have transformed our ability to treat 
bacterial infections. However, antibiotic overuse has allowed 
the evolution of antibiotic resistant bacteria that can survive 
the effect of an antibiotic. The emergence of antimicrobial 
resistance (AMR) is a global problem which is estimated to 
cause, 671 000 infections per year in the European Union alone 
(Cassini et al., 2019) and a further 33, 000 deaths (European 
Commission, 2018). In England, public health efforts to tackle 
AMR have led to declines in antibiotic use across healthcare 
settings, but rates of prescribing remain high compared to 
some other European countries (ESPAUR, 2018). Most impor-
tantly, the number of drug-resistant infections continues to rise 
(Cassini et al., 2019), highlighting the need for renewed efforts to 
improve the quality of antibiotic prescribing.
In the UK, the national action plan (DHSC, 2019) outlines a 
range of approaches to reduce AMR. Antibiotic stewardship, 
defined as “…an organisational or healthcare-system-wide 
approach to promoting and monitoring judicious use of antimi-
crobials to preserve their future effectiveness.” (NICE: 2015 p8) 
plays a critical role in this (DoH, 2013; WHO, 2015). A wide 
range of interventions have been found to improve antibiotic 
stewardship when applied across diverse healthcare settings 
(Davey et al., 2015; Hulscher & Prins, 2017). Effect sizes 
vary markedly, however, with apparently similar interventions 
producing very different results (Davey et al., 2017).
Behaviour change is key to combating AMR - in terms of 
appropriate antibiotic prescribing, infection prevention & control 
and use of diagnostics. Yet reviews to date show behavioural 
and social influences are often not given due consideration in 
design of stewardship programmes (Charani et al., 2011). Ration-
ales for intervention designs are often not given, and the range 
of behaviour change techniques used are limited (Davey et al., 
2017). There have thus been calls for the adoption of a multi-
disciplinary approach to designing stewardship interventions 
(Hulscher & Prins, 2017).
Medical Research Council guidance advocates a systematic, 
theory-based approach to intervention development, piloting, 
and evaluation (MRC, 2006), and a number of frameworks from 
the behavioural sciences have been developed to facilitate this. 
For instance, the Behaviour Change Wheel approach (Michie 
et al., 2011; Michie et al., 2014) advocates three key steps in 
the intervention development process: step 1) defining the 
problem of interest in behavioural terms (i.e. who/what/where/
when); step 2) conducting a behavioural diagnosis to identify 
the range of individual, socio-cultural and environmental factors 
influencing the behaviour; step 3) using findings from behav-
ioural diagnosis as a basis for selecting interventions, strategies 
and components that are likely to target any barriers/enablers to 
behaviour change (Michie et al., 2014).
Different disciplines offer evidence, theories, frameworks, and 
methods that hold the potential to facilitate each of these steps. For 
instance, to facilitate step 1: epidemiological analyses of antibiotic 
prescribing can inform more precise and evidence-based 
specification of the target behaviour by providing information 
that identifies and prioritises patient groups, types of pre-
scribing, stage of the prescribing process (antibiotic initiation 
versus de-escalation) and healthcare professional roles involved 
in prescribing. To facilitate step 2: behavioural science offers 
integrated theories and frameworks, such as the Theoretical 
Domains Framework (Michie et al., 2005) and the Capabil-
ity, Opportunity, Motivation – Behaviour (COM-B) (Michie 
et al., 2011) that summarise the individual, socio-cultural, and 
environmental influences on behaviour. These can be used to 
explore influences on the behaviour of interest, using a range 
of methodological approaches (qualitative interviews, surveys, 
evidence synthesis). This can be complemented by social 
science methods, such as ethnographic observations, that can 
help develop a deep contextual understanding of what drives 
current behaviours and what needs to be targeted to enable 
change. In particular, these methods allow us to think about why 
an intervention that works in a particular setting might fail in 
another or show remarkably different effects. To facilitate 
step 3: The Behaviour Change Technique (BCT) taxonomy 
v1 and Behaviour Change Wheel (Michie et al., 2011; Michie 
et al., 2013) can identify and categorise component BCTs 
and intervention functions in existing interventions, and iden-
tify those associated with improved effectiveness. Lastly, these 
frameworks can be mapped against one another to suggest 
types of intervention strategies that are likely to be effective and 
relevant in addressing different types of barriers and enablers 
(Cane et al., 2015; Michie et al., 2014).
Whilst the above frameworks can signpost types of interventions 
that are likely to be relevant, user-centred design methods can 
engage with potential users as experts, throughout the develop-
ment period in order to ensure that stewardship interventions are 
relevant to stakeholders and designed in a way such that they 
can be successfully delivered and operationalised (Chandler 
et al., 2016; Steen et al., 2011). This work can be guided by the 
Double Diamond design process model illustrated in Figure 1. 
This describes the design process in 4 phases, “Discover” 
(gathering insights) “Define” (frame the design question), 
“Develop” (testing solutions) and “Delivery” (production of 
the solution). This model has been widely applied to multidisci-
plinary design research and the generation and development of 
design solutions for user-centred problems (Design Council, 
undated) – including health care challenges (Chandler et al., 2016; 
Steen et al., 2011; West et al., 2017).
This protocol describes the structure and planned methods of 
the Preserving Antibiotics through Safe Stewardship (PASS) 
research programme, funded by the Economic and Social Research 
Council. The PASS interdisciplinary team involves researchers 
with expertise in design, psychology, behaviour change, social- 
science, and epidemiology. The project is a three-year programme 
of research structured around three sequential work-packages 
investigating antibiotic use in primary-care, secondary-care, 
care-homes, community pharmacy and amongst the general 
public.
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Figure 1. The Double diamond model.
The overarching aim of PASS is to identify patterns and drivers 
of antibiotic use across care settings, as a basis for developing 
theory-, and evidence-based antimicrobial stewardship interven-
tions. Specific objectives and research questions for individual 
work-packages are outlined in the Methods section.
Methods
Study design
Mixed-methods study (see Table 1 below)
Settings
Primary-care, secondary-care, care-homes, community, community 
pharmacy (see Table 1).
Research question
Research questions for the three work-packages, data sources and 
settings are summarised in Table 1 below.
Ethics approval and consent to participate
WP1: Use of CPRD was approved by the Independent Science 
Advisory Committee (ref ISAC-Nr: 17_048). Analysis of patterns 
of prescribing in secondary-care from a single Trust (using 
de-identified data) was registered as an audit and was not subject 
to ethical approval. The use of care-home data was approved 
by the UCL ethics committee (Ref: 11813/002) Ethical approval 
for the Bug Watch Survey was given by the UCL Ethics committee 
(ref: 11813/001)
WP2: Semi-structured interviews and observations and design-led 
workshops in care-homes, primary-care and secondary-care 
were ethically approved by the Westminster REC (ref: 235444). 
Semi-structured interviews with Bug Watch participants and 
community pharmacists were approved by UCL ethics committee 
(ref:13355/001).
Participants in the Bug Watch Survey and those taking part 
in semi-structured interviews will be required to provide 
informed consent before participating. All other parts of the 
study involve anonymised data and informed consent will not be 
required.
WORK-PACKAGE 1 (WP1). – IDENTIFYING PATTERNS OF 
ANTIBIOTIC PRESCRIBING 
High quality information on prescribing patterns, the management 
of infection and clinical outcomes across healthcare settings in 
England is currently lacking. WP1 addresses this by evaluating 
antibiotic prescribing in primary-care, secondary-care and care 
homes through an epidemiological analysis of electronic health 
records, care-home administrative data and pharmacy records, 
and by developing an online survey of patients in the community, 
the “Bug Watch” survey (Smith et al., 2019). These findings will 
provide insight into where problems lie and where intervening 
will be of greatest value. These analyses will also help define the 
target behaviours to be explored in interviews and observations in 
work-package 2, as well as sampling of participants/sites. Specific 
research questions for WP1 are presented in Table 1.
Procedure
Primary-care. A retrospective cohort study of patients registered 
with Clinical Practice Research Datalink (CPRD) practices, with 
a nested Cohort study of those presenting with common acute 
infections.
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Table 1. Protocol for the Preserving Antibiotics through Safe Stewardship (PASS) research questions, presented according to  
work-package and applicability to care settings.
WORK-PACKAGE 1 (WP1) : IDENTIFYING PATTERNS OF ANTIBIOTIC PRESCRIBING
Data sources: Primary–care: electronic health records (EHR), secondary-care: EHR, Care-home: Administrative data and pharmacy 
records, Community (Bug Watch): online prospective survey, Community pharmacy: n/a
Question Primary-
care
Secondary-care Care-homes Community Pharmacy
What is the frequency of antibiotic prescribing? ✓ ✓ ✓ ✓ n/a
Who gets antibiotics and why? ✓ ✓ ✓ ✓ n/a
Is prescribing appropriate? ✓ ✓ ✓ n/a n/a
What is the frequency of re-consultation or hospital admission ✓ n/a n/a n/a n/a
What proportion of patients with symptoms consult their GP n/a n/a n/a ✓ n/a
WORK-PACKAGE 2 (WP2) – IDENTIFYING BARRIERS AND ENABLERS TO STEWARDSHIP IN CONTEXT 
Data sources: Primary–care, secondary-care, care-homes: interviews, observations, design workshops, systematic review Community 
& Community Pharmacy: interviews, systematic review
Primary-
care
Secondary-care Care-homes Community Pharmacy
Interviews: What are the barriers to, and facilitators of, 
antibiotic prescribing?
✓ ✓ ✓ n/a ✓
Interviews: What drives patients to seek antibiotics for their 
symptoms?
n/a n/a n/a ✓ n/a
Observations: What are the contextual factors that underpin 
variations in prescribing?
✓ ✓ ✓ n/a n/a
Observations and interviews: What are staff experiences 
of, attitudes towards and uptake of existing interventions to 
optimise prescribing?
✓ ✓ ✓ n/a ✓
Systematic Reviews: What interventions are effective in 
improving stewardship?
✓ ✓ ✓ ✓ ✓
Systematic Reviews: Which behaviour change techniques 
have been used in existing interventions, and which are 
associated with increased effectiveness?
✓ ✓ ✓ ✓ ✓
Design workshops: Which are the practical and feasible 
entry points for interventions?
✓ ✓ ✓ Data not 
collected
Data not 
collected
Design workshops: What are the constraints that impact the 
form of the intervention?
✓ ✓ ✓ Data not 
collected
Data not 
collected
WORK-PACKAGE 3 (WP3)– CO-PRODUCTION OF INTERVENTION BUNDLES AND DISSEMINATION 
Data sources: All settings: Triangulation of systematic review findings against findings from WP1 and WP2, stakeholder workshops.
Primary-
care
Secondary-care Care-homes Community Pharmacy
Triangulation: Do existing interventions target key drivers of 
antibiotic prescribing?
✓ ✓ ✓ ✓ ✓
Triangulation: What interventions are likely to be effective and 
relevant?
✓ ✓ ✓ ✓ ✓
Stakeholder workshops: What are stakeholder views on how 
bundles can best be delivered?
✓ ✓ ✓ ✓ ✓
Stakeholder workshops: Which interventions meet the 
APEASE criteria and should be prioritised?
✓ ✓ ✓ ✓ ✓
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The CPRD is a primary-care dataset containing de-identified 
data from 11 million currently registered patients from a network 
of GP practices across the UK. All patients who were registered 
with a general practice between January 1st 2008 and December 
31st 2015 are eligible for inclusion, provided their data met 
specified quality standards (Herrett et al., 2015). A subset of the 
dataset is linked to information on hospital admissions through 
hospital episode statistics (HES) and census data through the 
Office of National Statistics. Using this dataset, we will extend 
an existing analysis (Shallcross et al., 2017) and examine which 
patients (in terms of age, gender, comorbidities, socioeconomic 
variables, obesity, and smoking) receive the most antibiotics. 
This will identify which patients are most likely to receive 
antibiotics, for which infections and with what treatment 
regimes. These will be related to national guidance (NICE, 2015) 
on primary-care antibiotic prescribing to assess appropriateness.
In the nested cohort study we will investigate adverse 
outcomes (risk of re-consultation, hospitalisation and death 
within 28 days) in patients who present to primary-care with 
specific clinical infection syndromes, comparing patients who 
were/were not treated with antibiotics.
Data analysis and statistical plan: Using statistical approaches 
such as propensity scores we will estimate the absolute risk 
and number-needed-to-treat (NNT) with antibiotics to prevent 
adverse outcomes.
Care-homes. A descriptive analysis of routine data from a 
national chain of >300 care-homes, linked, at the level of 
individual residents, to antibiotic dispensing data for the same 
period will be carried out.
Prescribing data are supplied by a national chain of pharmacies; 
the sole provider of dispensing services to these care-homes 
and includes the type of drug, duration, dose and route of 
administration. Data from the care home are derived from a 
number of databases held by the care-home provider and 
includes information on incident reporting (Datix), demographic 
characteristics of residents, and characteristics of the care-
home (including staffing, resident numbers, resident types and 
location). Records will be extracted for individuals who 
were care-home residents between January 1st, 2016 and 
December 31st, 2017.
Data analysis and statistical plan: We will identify the major 
infection categories leading to antibiotic use, the antibiotics used 
and the characteristics of residents receiving antibiotics. We 
will generate home-specific rankings of antibiotic use to divide 
homes into quintiles for sampling in WP2.
Secondary-care. A descriptive analysis of data from electronic 
health records, derived from a large teaching hospital in central 
England will be carried out. This is a unique data-holding 
that includes high-resolution, anonymised data on symptoms, 
diagnoses, co-morbidities, prescriptions, test results, and vital 
signs, and information on long-term clinical outcome through 
linkage to death certifications and hospital episode statistics. 
Data will be extracted for every patient who was admitted to this 
hospital and prescribed at least one antibiotic between January 1st, 
2011 and December 31st, 2016.
Data analysis and statistical plan: The analysis will include a 
description of the distribution of antibiotic prescribing accord-
ing to clinical indication, patient group, clinical speciality, pre-
scriber seniority and period. Clinical indications will be derived 
from symptoms, vital signs and biomarkers recorded during 
admission, and ICD-10 codes allocated at discharge from the 
hospital. We will investigate the appropriateness of high volume 
antibiotic prescribing in up to five clinical specialities; taking 
account of factors such as age and co-morbidities which might 
influence prescribing decisions. This work will inform selection 
of wards and teams for inclusion in WP2.
Community/general population (Bug Watch Survey). A prospec-
tive community cohort study entitled Bug Watch will be carried 
out. We will invite 21745 adults who previously took part in the 
Health Survey for England, and agreed to be contacted for 
further research (Smith et al., 2019), along with children liv-
ing in these households. All participants in the Health Survey 
for England in 2013, 2014 and 2015 who also agreed to be 
contacted re further research will be eligible for inclusion.
Information on participants will be captured through an online 
survey which collects baseline information on participant 
characteristics including: demographics, presence of comorbidi-
ties, and knowledge of antibiotics. Once enrolled, participants 
will receive a weekly email over a six-month period inviting them 
to record possible symptoms of infection that they experienced 
in the prior week, such as coughs, fever, rash, diarrhoea. Those 
reporting symptoms will be asked to record whether they sought 
help from a healthcare provider, whether they requested and/
or received antibiotics, and factors influencing their healthcare 
and antibiotic seeking behaviours based on the COM-B model 
(Michie et al., 2011). Parents will be asked to complete surveys 
on behalf of children.
Study data will be collected and managed using REDCap 
electronic data capture tools hosted at University College 
London REDCap (Research Electronic Data Capture) is a 
secure, web-based software platform designed to support data 
capture for research studies (Harris et al., 2009).
Data analysis and statistical plan: The proportions of people 
with common symptoms of infection who consult their GP and 
receive antibiotics will be estimated. We will investigate 
how these healthcare-seeking and treatment behaviours vary 
by age, gender, ethnicity, presence of other illnesses, social 
deprivation, symptom duration and severity.
WORK-PACKAGE 2 (WP2) – IDENTIFYING BARRIERS AND 
ENABLERS TO STEWARDSHIP IN CONTEXT 
WP2 draws on theory, methods and principles from the behav-
ioural and social sciences to investigate factors influencing anti-
biotic prescribing in context. Findings from WP1 will facilitate 
specification of the target behaviours to be investigated in WP2, 
by providing an evidence base for specifying who/what/where/
when (i.e. identify target patient groups, the time frame, types of 
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antibiotics, and prescribers). For each setting, we will conduct: 
1) theory-based semi-structured interviews to identify barriers 
and enablers to appropriate antibiotic prescribing; 2) ethnographic 
observations to investigate socio-cultural and contextual factors 
shaping antibiotic use, 3) systematic reviews to specify the 
active ingredients (i.e. behaviour change techniques) of existing 
antimicrobial stewardship interventions and 4) designer led 
workshops to explore initial intervention generation. Specific 
research questions for WP2 are outlined in Table 1.
Procedure
Semi-structured interviews. Semi-structured interviews will be 
carried out with healthcare professionals in primary-care (4 sites 
in England), community pharmacy (up to 16 sites in England), 
secondary-care (4 wards/consultant teams in an English teach-
ing hospital), and care-homes (4 homes in England) and with 
members of the public (recruited via the Bug Watch survey). 
Healthcare sites will include a mix of high and low prescribing 
sites. Care-homes and wards/consultant teams will be purposively 
sampled based on prescribing patterns data from WP1 and primary 
care sites, using data available from the Public Health England 
“Fingertips” platform. A purposive sample of Bug Watch par-
ticipants, who agreed to be contacted, had symptoms of infection 
and did or did not seek antibiotics from their GP for experienced 
symptoms will be invited to participate. A convenience sample of 
pharmacists will be used.
We will conduct a minimum of 16 interviews per care setting 
(n= 8 from two high prescribing general practices/wards/ 
care-homes, n = 8 from two low prescribing general practices/ 
wards/care-homes, n=8 Bug Watch participants that sought 
antibiotics, n=8 Bug Watch participants that did not seek 
antibiotics, n=16 community pharmacists), 80 interviews in 
total. We will assess for thematic data saturation following the 
interviews, and conduct further interviews as needed until data 
saturation is achieved (Francis et al., 2010).
The overall target behaviour to be explored in interviews 
conducted in healthcare settings is antibiotic use (including 
the sub-behaviours around prescribing, reviewing, switching, 
stopping antibiotics, advice giving, infection management). We 
will further specify this based on WP1 findings (e.g. prescribing 
of antibiotics for specific patient groups, types of antibiotics, 
times/days of week etc). The target behaviour to be explored in 
interviews conducted with Bug Watch participants is antibiotic 
and healthcare seeking for symptoms. Topic guides (see 
extended data (Shallcross et al., 2020)) for all settings will be 
based on the Theoretical Domains Framework (TDF) (Cane 
et al., 2012), which synthesises 33 behaviour change theo-
ries into 14 domains representing the range of individual, 
socio-cultural and environmental influences on behaviour. 
The topic guide will include at least 1 question per domain, 
and will be developed in collaboration with healthcare 
professionals, behavioural scientists and patient and public 
representatives. The topic guide will be piloted with at least 
two participants prior to data collection. Interviews lasting a 
maximum of one hour will be conducted either face to face or 
via telephone. Interviews will be audio-recorded, transcribed 
verbatim and fully anonymised so that no individual or 
organisation can be identified from the data. The researcher will 
record interviews using an encrypted recorder. This will then be 
transcribed by a University approved supplier, with a signed 
confidentiality and data management agreement in place. Once 
transcripts are completed and checked, recordings will be 
deleted.
Data analysis: Transcripts will be analysed using a combined 
deductive framework and inductive thematic analysis approach, 
in line with recently published guidance (Atkins et al., 2017). 
Participant responses will be deductively coded into the TDF 
domain they are judged to best represent. Subsequently, similar 
responses within each domain will be grouped, and a theme 
label inductively generated. Theme labels will summarise 
the role that domain plays in either facilitating or hindering 
appropriate antibiotic use. Key domains will be identified using 
established criteria: frequency, expressed importance, and 
discord (Atkins et al., 2017). Findings in high vs low prescrib-
ing participants will be compared, as well as according to 
professional roles (e.g. nurses vs physicians). Analysis will be 
conducted separately for each care setting first, and subsequently 
compared.
Ethnographic observations. Ethnographic observations of 
practice will be undertaken in areas where semi-structured 
interviews have taken place (4 primary care practices, 4 nursing 
homes, and 4 secondary care consultant teams). We will develop 
a structured observation guide based on findings from WP1 
and drawing on Bate’s framework of context in improvement to 
identify sensitising concepts (Bate, 2014). A researcher will 
visit each site for up to five days and observe clinical practice, 
shadow staff, and collect local documents and guidelines.
The researcher will gather data on salient features of the local 
systems, social factors, and organisational context that may 
impact on local prescribing patterns. Data will be in the form of 
field notes from observations, audio recordings of the observer’s 
reflections and discussions with healthcare-workers, patients, 
and relatives. The researcher will record their impressions 
using an encrypted recorder. This will then be transcribed by a 
University approved supplier, with a signed confidentiality 
and data management agreement in place. Once transcripts are 
completed and checked, recordings will be deleted. Field notes 
and audio recordings will be transcribed verbatim and coded 
using NVivo software (version 12).
Data analysis: The analysis will draw on elements of grounded 
theory, in particular, the constant comparative approach 
(Charmaz, 2014), and will aim to generate accounts of the 
influence of social and contextual factors on antibiotic use in 
different settings. We will use techniques including diagram-
ming and theme summaries to synthesise our findings (Charmaz, 
2014). Analysis of interview and observational data will be 
supported through regular discussion between researchers to 
ensure that the findings can be brought together to generate a 
more comprehensive picture of influences on behaviour that will 
be taken into account in intervention design.
Evidence synthesis. Systematic reviews of published antimicro-
bial stewardship interventions will be carried out for primary-care, 
secondary-care, care-homes, community pharmacy and general 
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population. The reviews aim to establish the effectiveness of 
interventions targeting AMS and what content contributes to 
intervention effectiveness (see Table 1 for specific research 
questions). Review protocols will be registered on PROSPERO 
and will be conducted in accordance with PRISMA guidelines 
(Moher et al., 2009). The systematic reviews will be conducted 
using EPPI-Reviewer version 4 (EPPI-Centre, 2010): a com-
prehensive online software tool for research synthesis enabling 
management and analysis of literature review data. The software 
will be used to manage all stages of the process from bibliographic 
management, screening, coding, and synthesis.
We will first conduct a scoping search to identify existing 
reviews and/or registered protocols of reviews of antimicrobial 
stewardship interventions in primary-care, secondary-care, care-
homes, and community pharmacy, plus interventions influencing 
antibiotic seeking and infection management in the general 
population. Where an existing review does not exist, we will 
conduct a systematic search of electronic data bases (Medline, 
PubMed, EMBASE, PsychInfo) and hand searches of reference 
lists, to identify published evaluations of interventions targeting 
antibiotic stewardship in the given care setting. Language will 
be restricted to English. No publication date restrictions will be 
imposed on the search algorithms. Where a recently published, 
comprehensive review exists, we will conduct a secondary analysis 
of interventions included in that review.
Titles, abstracts and full texts will be screened against pre- 
specified inclusion criteria (randomised trials, observational 
studies, systematic reviews) and exclusion criteria (qualitative 
studies, grey literature, case-studies). Of these, 25% will be 
double-screened by two reviewers at each step. Quality appraisal 
of all included studies will be undertaken using the Cochrane 
risk of bias tool (randomised studies) and the ROBINS-I tool 
(non-randomised studies).
The behavioural outcome of interest is antibiotic, - prescribing, -
dispensing or -consumption. The outcome may be measured as 
the total amount prescribed, dispensed or consumed; or as the 
proportion of antibiotics appropriately prescribed, dispensed or 
consumed.
Data analysis and statistical plan: A pre-designed proforma 
will be used to extract data on study characteristics, behavioural 
outcomes and effect sizes. Data extraction will focus on the 
following: publication details, clinical/demographic charac-
teristics, study design/methods, intervention types, outcomes, 
data-collection method and statistical analyses. Data on the 
behaviours being targeted will also be extracted: specified 
according to the TACTA framework Action, Actor, Context, Time-
frame, Target (Presseau et al., 2019). A full list of fields used for 
data extraction in the pro-forma are provided as extended data 
(Shallcross et al., 2020).
We will apply the Behaviour Change Wheel (Michie et al., 
2011) and the Behaviour Change Technique taxonomy v1 
(Michie et al., 2014) to identify and categorise the intervention 
functions and behaviour change techniques (BCTs) reported in 
the published descriptions of included interventions.
We will use descriptive statistics to summarise the use of inter-
vention functions and BCTs across trials. A narrative synthesis 
will also be conducted. The impact of type and number of interven-
tion functions and BCTs on effect size will be investigated
Where feasible, the data will be synthesised through meta-
analysis using the random effects inverse variance method to 
establish pooled effect sizes for interventions and their compo-
nents. The consistency of the results from each study will also 
be assessed by a forest plot and the degree of heterogeneity 
will be determined using the χ² test and the I² statistic.
We will also conduct meta-regressions in sub-group analyses 
to explore which specific intervention functions and BCTs are 
associated with improved effectiveness. Such findings can inform 
the selection of potential components to include in the design 
and/or refinement of future interventions to improve antibiotic 
stewardship. Such findings can inform the selection of potential 
components to include in the design and/or refinement of future 
interventions to improve antibiotic stewardship.
Design-led workshops. Workshops will be carried out that will 
extend and complement the interviews and observations. We 
will work in 1–2 sites each in primary-care, secondary-care and 
care-homes, where interviews and observations have already 
been carried out. We will work with health care teams at selected 
sites, and invite participation from a variety of clinical, support 
and ancillary staff. Individual and group activities will engage 
healthcare staff in creative ways to understand their experience 
and expertise around antibiotic use. Workshops will employ a 
combination of inclusive-design research tools and techniques. 
Techniques will include imagining and drawing personal 
ideals; describing tasks or reflecting on strategies using visual 
worksheets; problem-solving or ideating impossible scenarios. 
A variety of tools will be used, such as playing cards to indicate 
feelings; voting or ranking tasks; simulation and substitu-
tion games for creative problem-solving. Inspiration for these 
have been drawn from a number of sources and disciplines, 
including creative thinking theorists such as De Bono, IDEO 
design group methods, human factors theory and practice, and 
inclusive design methodologies (www.designingwithpeople.org, 
2019).
WORK-PACKAGE 3 (WP3) – CO-PRODUCTION OF INTER-
VENTION BUNDLES AND DISSEMINATION 
In WP3 PASS researchers will work with the public and 
healthcare practitioners to develop intervention bundles where 
there is scope to improve stewardship, employing structured-
approaches commonly used in the behavioural sciences (Michie 
et al., 2014) combined with principles of user-centred design 
(Steen et al., 2011). An online platform to disseminate PASS 
outputs will also be developed.
Procedure
Triangulation: We will host data triangulation workshops with 
research team members from each work-package in order to 
integrate and compare findings across work-packages. In the 
first instance, this will be done for each care setting individually. 
The aim of the workshops will be to identify commonalities 
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and consistent themes and findings emerging from each work 
package, as well as areas of discord. Following published data 
triangulation procedures (Farmer et al., 2006; Hopf et al., 
2016; Tonkin-Crine et al., 2016), we will tabulate key findings 
from each work-package and record whether these findings are 
convergent with-, divergent from-, or absent from findings of 
other work-packages. We will look for consistent themes across 
data sources regarding patterns and influences on antibiotic 
prescribing in each care setting.
Analysis plan: Consistent themes across data sources repre-
sent potential challenges to be addressed by antimicrobial 
stewardship interventions. We will therefore design interventions 
to target these themes. First, we will follow the steps in the 
Behaviour Change Wheel approach to systematically identify 
types of intervention functions and BCTs that are theoretically 
congruent with, and likely to be relevant and effective in, 
addressing the key barriers and enablers identified in WP2. This 
will be done by consulting the mapping matrices (Cane et al., 
2015; Michie et al., 2014) which pair intervention functions 
from the Behaviour Change Wheel (Michie et al., 2011) and 
BCTs from the taxonomy v1 (Michie et al., 2014) with domains 
from the TDF (Cane et al., 2012), on which the WP2 interviews 
are based. This will generate a long list of potential intervention 
components. We will prioritise amongst these by using evidence 
from the WP2 systematic reviews regarding which intervention 
functions and BCTs are associated with increased effectiveness 
in improving AMS behaviours. This will result in a final set of 
candidate intervention bundles.
Stakeholder workshops: Candidate intervention bundles will 
then be presented and discussed in a series of co-design work-
shops with key stakeholder representatives, such as healthcare 
professionals, policy makers, patient and public representatives, 
multidisciplinary researchers. Project staff will use research 
publications, personal contacts and knowledge of the field to 
identify relevant stakeholders, who will be invited via email. We 
will use the ‘people in research’ website to identify and invite 
patient/public representatives.
Stakeholders will be asked to discuss each bundle in turn using 
the APEASE criteria to help select between these potential 
interventions (i.e. Acceptability, Practicability, Effectiveness, 
Affordability, Side-Effects, Equity) (Michie et al., 2014). To 
provide context and guide discussions, stakeholders will also 
be presented with summaries of the study findings. Nominal 
group techniques (Harvey & Holmes, 2012), will be used to help 
reach consensus on which interventions are most likely to be 
appropriate, effective, and feasible to deliver in local context and 
ways of working.
Analysis plan: Following completion of the stakeholder work-
shops, the design team will develop the most promising 
intervention concepts through a series of design iterations. This 
will involve further co-design work with healthcare staff and 
stakeholders, whereby each concept will undergo a ‘design sprint’ 
moving from concept materialisation (prototyping, mock-ups), 
to user-testing and review. The design sprints will ensure that 
the intervention concept meets its goal, that micro and macro 
feasibility issues are identified and problem-solved, and that 
functionality and efficiency are secured as far as possible. 
PASS sprints will establish a meshing of inclusive design tech-
niques (both research and design development) with LEAN 
(Jauregui-Becker & Perry, 2015) or rapid iterative design proc-
esses (Medlock et al., 2002). We will then develop interven-
tion descriptions, protocols, and materials to take forward to 
formal pilot/feasibility testing and outcome evaluation.
Dissemination of information
Anonymised summary data will be made available via the PASS 
website and will be searchable via the UK Data Service.
Summaries of available evidence on AMS across these settings, 
and the key findings from each WP in PASS will be made 
available as a resource for patients, the public, policymakers and 
healthcare professionals through an interactive website that 
will be developed in consultation with stakeholder panels. We 
will develop patient and public infographics supporting safe 
self-management of infection and shared decision-making. The 
website will also act as a practical guide for researchers, policy 
makers, and practitioners to help support selection and design 
of AMS intervention for different antibiotic use contexts and as 
a resource for researchers. Where appropriate the website will 
link to existing resources of information to avoid duplication of 
materials.
Study status
Data collection for work-package one is complete and 
analysis is ongoing. Data collection and analysis for work- 
package 2 is ongoing. Expected date of project completion 
July 2020.
Discussion
This programme of research will take an inter-disciplinary, 
theoretically and empirically-informed approach to developing 
AMS interventions across the UK healthcare economy. We will 
use quantitative and qualitative methods, design-led research, 
evidence synthesis, systematic approaches to behavioural interven-
tion design, and evidence based participatory design principles, 
to design robust and effective theory-based interventions.
The knowledge generated by this programme of work will 
include extensive data that characterises infection manage-
ment, infection outcomes, and antibiotic use, across commu-
nity, primary-care, secondary-care, and nursing home settings. 
Quantitative data on patterns of antibiotic prescribing at an 
individual patient level are currently most sparse in nursing 
home-, and hospital-settings. Information on self-management 
of infections in the community and patterns of health-seeking 
behaviours is also lacking. We would expect these findings to be 
of particular interest to researchers, clinicians and policy-makers 
involved in the field of AMR, as well as to a wider-audience. 
Although our quantitative analyses of prescribing are of UK 
data we expect that scientists studying prescribing in different 
countries will be keen to use the data to make international 
comparisons. Measures of disease natural history and outcomes 
in treated and untreated patients will be broadly generalisable 
across high and middle-income settings.
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Data on prescribing patterns will help us to more precisely 
specify the target behaviours for intervention, by revealing the 
most problematic areas of antibiotic over-use, help us define the 
problem in behavioural terms (for instance with whom, where 
and when to intervene) and to allow purposive sampling for 
WP2. This will enable effort to be focused on the points in 
care where there are the most gains to be made in intervening 
to improve antibiotic use. Generating comprehensive data on 
prescribing patterns and infection outcomes may also, in itself, 
open up new possibilities for intervention design that are 
dependent on such data.
The qualitative work will provide insights into professional and 
public behaviour including improved understanding of how 
people balance risks and benefits and the pressures that make 
it difficult to adhere to national and local guidance. We will 
structure our findings and our review evidence using increas-
ingly applied theoretical frameworks from the behavioural 
and social sciences (Michie et al., 2014). This approach will 
enable researchers to draw comparisons with our research 
more readily. We anticipate these findings will also be of rel-
evance to researchers studying health care seeking and treatment 
behaviours in non-infection-related areas.
Our systematic approach to intervention development will 
allow other researchers who wish to test the effectiveness of 
stewardship approaches to select candidate intervention bundles. 
Our website will support this process by highlighting what 
behaviours need changing in different contexts, highlighting 
important drivers of these behaviours, showing what has been 
tried previously and suggesting combinations of interventions that 
are likely to work.
The planned work is highly inter-disciplinary, involving statisti-
cians, epidemiologists, psychologists, ethnographers, designers 
and clinicians. This approach to the understanding of antibiotic 
prescribing from quantitative and behavioural science per-
spectives is a major strength of the study, particularly when 
it comes to developing innovative solutions to the problem of 
antibiotic stewardship. However, it also presents significant 
challenges. In particular, we will need to take into account the 
different methods and goals of a multi-disciplinary team. As 
such the work is likely to demonstrate a degree of complexity 
that will require a collegiate approach to management and 
leadership.
Conclusion
This protocol describes a complex programme of inter-disciplinary 
research which aims to co-design theory- and evidence-based 
antibiotic stewardship interventions targeted to specific health-
care settings. Our outputs will be of value to a wide range of 
stakeholders including: patients, the public, researchers from a 
range of disciplines (including behavioural science, epidemi-
ology, health informatics, health intervention design, health 
service researchers, trialists and mathematical modellers) 
within the UK and beyond, as well as healthcare workers and 
policy makers. Beyond this study, our aim is to pilot and trial 
the stewardship interventions that have been agreed to be 
most promising by our stakeholder panel, working towards 
implementation of effective AMS strategies in routine clinical 
practice.
Data availability
Underlying data
No data are associated with this article
Extended data
Figshare: An interdisciplinary mixed-methods approach to 
developing antimicrobial stewardship interventions: Protocol 
for the Preserving Antibiotics through Safe Stewardship (PASS) 
Research Programme: Supplementary materials. https://doi.
org/10.5522/04/11548497.v1 (Shallcross et al., 2020)
This project contains the following extended data:
-	 	PASS_protocol_supplementary_materials.docx (Docu-
ment containing interview schedules for primary-care, 
secondary-care and care-homes and the systematic 
review proforma for data extraction) 
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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From my understanding of the programme, work package 3 must marry the granular outputs from
previous work packages with the more practical insights and expertise of the stakeholders. How are the
team considering how to manage this? Will some of what has been gained from the granularity of
approach be lost? On a more practical level, how many participants will there be within this work package,
which sampling approach will be taken to recruit them, how will there particular expertise be weighted?
How will the specific language of the behavioural science (eg. BCTs and TDF domains) be translated and
made meaningful for the workshop attendees?
I also felt there was an unexplained shift in the pitch of intervention content as the programme develops.
The protocol moves from the detailed understanding of what interventions could be made from (their
evidence-based and theoretically informed putative active ingredients, such as intervention functions,
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 evidence-based and theoretically informed putative active ingredients, such as intervention functions,
TDF domains or BCTs), to the more general term ‘intervention bundles’. Sorry if I have missed the
explanation, and a rationale for the shift in the loci of change, or how it is operationalised across all the
relevant health care settings but I found this shift to be a bit confusing. The team appear pragmatic in
relation to behavioural specificity across the programme and I wonder if a pragmatic approach here is
being planned too? More detail would help.
Equally, some of the methods proposed here (i.e., nominal group techniques) may focus too inwardly on
understanding intervention components able to moderate prescribing behaviour. Perhaps the adoption of
this approach alone neglects the incorporation of stakeholder insights into future implementation and
wider health care systems-level phenomena. On a more basic level, it would be helpful to have a little
more explanatory detail for approaches such as ‘LEAN’ or ‘design Sprints’.
Again, as a minor point, I wondered about the Bug Watch Survey and whether information about pets and
antimicrobials was being recorded.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Not applicable
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